Literature DB >> 35384449

Effect of Nanosulfur Against Multidrug-Resistant Staphylococcus pseudintermedius and Pseudomonas aeruginosa.

Lopamudra Kher1, Domenico Santoro2, Karen Kelley3, Daniel Gibson4, Gregory Schultz4.   

Abstract

Multidrug resistance (MDR) has significantly increased in the past decades and the use of nanotechnology has opened new venues for novel treatments. Nanosulfur is a potent antimicrobial agent and a cheaper alternative to other nanomaterials. However, very few studies have been published on its activity against MDR organisms. Therefore, the goal of this in vitro study was to assess cytotoxicity, antimicrobial, and anti-biofilm activity of nanosulfur (47 nm, orthorhombic) against clinical isolates of MDR Staphylococcus pseudintermedius (SP) and Pseudomonas aeruginosa (PA) in planktonic and biofilm state using canine skin explants. Nanosilver (50 nm, spherical) was tested as a comparative control. Concentrations between 1866.7 and 0.11 μg/mL of both nanoparticles were tested. The ultrastructure of nanosulfur was assessed via electron microscopy. Both types of nanoparticles showed no direct cytotoxicity on a canine keratinocyte cell line. In the planktonic phase, nanosulfur was able to inhibit or kill (6-log10 reduction of CFU) 7 of 10 MDR-SP isolates at 233.3 μg/mL, whereas, when in biofilm state, 6 of 10 isolates were killed at different concentrations (233.33 to 1866.7 μg/mL). Nanosilver did not show any antimicrobial or anti-biofilm activity at any concentrations tested. Both types of nanoparticles were ineffective against MDR-PA in either state. Ultrastructurally, nanosulfur was present in individual nanoparticles as well as forming larger nanoclusters. This is the first study showing an antimicrobial and anti-biofilm activity of nanosulfur for MDR-SP in absence of cytotoxicity. Nanosulfur has the potential to be used in veterinary and human medicine as effective, safe, and cheap alternative to antimicrobials and anti-biofilm agents currently available. KEY POINTS: • Nanosulfur is a better alternative than nanosilver to treat MDR-Staphylococci. • Nanosulfur is an effective agent against MDR-Staphyloccocal biofilm. • Canine skin explant model is reliable for testing anti-biofilm agents.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Biofilm; Multidrug resistance; Nanosilver; Nanosulfur; Pseudomonas aeruginosa; Staphylococcus pseudintermedius

Mesh:

Substances:

Year:  2022        PMID: 35384449     DOI: 10.1007/s00253-022-11872-8

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   5.560


  20 in total

Review 1.  "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era.

Authors:  Ae Jung Huh; Young Jik Kwon
Journal:  J Control Release       Date:  2011-07-06       Impact factor: 9.776

2.  Antimicrobial effects of silver nanoparticles.

Authors:  Jun Sung Kim; Eunye Kuk; Kyeong Nam Yu; Jong-Ho Kim; Sung Jin Park; Hu Jang Lee; So Hyun Kim; Young Kyung Park; Yong Ho Park; Cheol-Yong Hwang; Yong-Kwon Kim; Yoon-Sik Lee; Dae Hong Jeong; Myung-Haing Cho
Journal:  Nanomedicine       Date:  2007-03       Impact factor: 5.307

3.  Anti-biofilm properties of a mupirocin spray formulation against Escherichia coli wound infections.

Authors:  Dhamodharan Bakkiyaraj; Rutthapol Sritharadol; Alwar Ramanujam Padmavathi; Titpawan Nakpheng; Teerapol Srichana
Journal:  Biofouling       Date:  2017-07-07       Impact factor: 3.209

4.  Antibacterial effect of silver nanoparticles on Staphylococcus aureus.

Authors:  Wen-Ru Li; Xiao-Bao Xie; Qing-Shan Shi; Shun-Shan Duan; You-Sheng Ouyang; Yi-Ben Chen
Journal:  Biometals       Date:  2010-10-12       Impact factor: 2.949

Review 5.  The use of sulfur in dermatology.

Authors:  Aditya K Gupta; Karyn Nicol
Journal:  J Drugs Dermatol       Date:  2004 Jul-Aug       Impact factor: 2.114

6.  Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis.

Authors:  Kalimuthu Kalishwaralal; Selvaraj BarathManiKanth; Sureshbabu Ram Kumar Pandian; Venkataraman Deepak; Sangiliyandi Gurunathan
Journal:  Colloids Surf B Biointerfaces       Date:  2010-04-22       Impact factor: 5.268

7.  The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study.

Authors:  J Ena; R W Dick; R N Jones; R P Wenzel
Journal:  JAMA       Date:  1993-02-03       Impact factor: 56.272

Review 8.  Intrigues of biofilm: A perspective in veterinary medicine.

Authors:  Umar Faruk Abdullahi; Ephraim Igwenagu; Anas Mu'azu; Sani Aliyu; Maryam Ibrahim Umar
Journal:  Vet World       Date:  2016-01-02

Review 9.  Nanoparticles in the Treatment of Infections Caused by Multidrug-Resistant Organisms.

Authors:  Nan-Yao Lee; Wen-Chien Ko; Po-Ren Hsueh
Journal:  Front Pharmacol       Date:  2019-10-04       Impact factor: 5.810

10.  Evolution of the Population Structure of Staphylococcus pseudintermedius in France.

Authors:  Marine Bergot; Patricia Martins-Simoes; Hélène Kilian; Pierre Châtre; Kate A Worthing; Jacqueline M Norris; Jean-Yves Madec; Frédéric Laurent; Marisa Haenni
Journal:  Front Microbiol       Date:  2018-12-13       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.